Kiniksa Pharmaceuticals International, plc
KNSA
$19.31
$0.663.54%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 243.63M | 223.78M | 218.76M | 213.55M | 206.37M |
| Total Receivables | 41.72M | 24.89M | 20.45M | 16.00M | 21.27M |
| Inventory | 26.36M | 28.68M | 34.86M | 27.28M | 31.12M |
| Prepaid Expenses | 20.08M | 33.95M | 26.95M | 13.77M | 17.54M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 331.80M | 311.30M | 301.02M | 270.59M | 276.30M |
|
|
|||||
| Total Current Assets | 331.80M | 311.30M | 301.02M | 270.59M | 276.30M |
| Net Property, Plant & Equipment | 11.04M | 11.66M | 12.40M | 13.04M | 12.67M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 16.25M | 16.50M | 16.75M | 17.00M | 17.25M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 221.47M | 215.84M | 212.25M | 219.05M | 220.11M |
| Total Assets | 580.55M | 555.30M | 542.43M | 519.67M | 526.32M |
|
|
|||||
| Total Accounts Payable | 2.04M | 8.33M | 7.39M | 5.63M | 8.25M |
| Total Accrued Expenses | 80.51M | 69.53M | 63.32M | 44.72M | 44.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.99M | 2.03M | 2.09M | 2.28M | 2.25M |
| Total Finance Division Other Current Liabilities | 16.08M | 16.07M | 11.50M | 11.58M | 8.50M |
| Total Other Current Liabilities | 16.08M | 16.07M | 11.50M | 11.58M | 8.50M |
| Total Current Liabilities | 100.62M | 95.96M | 84.29M | 64.21M | 63.67M |
|
|
|||||
| Total Current Liabilities | 100.62M | 95.96M | 84.29M | 64.21M | 63.67M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.86M | 8.56M | 9.32M | 9.86M | 10.01M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 33.63M | 13.77M | 13.73M | 13.70M | 13.81M |
| Total Liabilities | 142.12M | 118.29M | 107.33M | 87.78M | 87.48M |
|
|
|||||
| Common Stock & APIC | 959.74M | 949.30M | 934.79M | 927.60M | 916.78M |
| Retained Earnings | -521.14M | -512.26M | -499.56M | -495.65M | -477.95M |
| Treasury Stock & Other | -163.00K | -41.00K | -130.00K | -53.00K | 6.00K |
| Total Common Equity | 438.44M | 437.01M | 435.10M | 431.90M | 438.84M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 438.44M | 437.01M | 435.10M | 431.90M | 438.84M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 438.44M | 437.01M | 435.10M | 431.90M | 438.84M |
|
|
|||||
